Positron Emission Tomography?Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00053032" target="_blank" >RIV/00216224:14110/11:00053032 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/65269705:_____/11:#0001363
Výsledek na webu
<a href="http://dx.doi.org/10.1200/JCO.2011.35.0736" target="_blank" >http://dx.doi.org/10.1200/JCO.2011.35.0736</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1200/JCO.2011.35.0736" target="_blank" >10.1200/JCO.2011.35.0736</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Positron Emission Tomography?Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
Popis výsledku v původním jazyce
The utility of [18F]fluorodeoxyglucose (FDG) positron emission tomography?computed tomography (PET-CT) in assessing response at the end of induction therapy is well documented in Hodgkin's and diffuse large B-cell lymphomas, but its role in follicular lymphoma (FL) remains undetermined. We investigated the prognostic significance of PET-CT performed after first-line therapy in patients with FL treated in the prospective Primary Rituximab and Maintenance (PRIMA) study. Results of PET-CT scans performed after induction immunochemotherapy were recorded retrospectively. Patients went on to either observation or rituximab maintenance per protocol independent of the PET-CT result. Patient characteristics and outcomes were then evaluated. Of 122 PET-CT scansperformed at the end of the induction immunochemotherapy, 32 (26%) were reported as positive by the local investigator.
Název v anglickém jazyce
Positron Emission Tomography?Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
Popis výsledku anglicky
The utility of [18F]fluorodeoxyglucose (FDG) positron emission tomography?computed tomography (PET-CT) in assessing response at the end of induction therapy is well documented in Hodgkin's and diffuse large B-cell lymphomas, but its role in follicular lymphoma (FL) remains undetermined. We investigated the prognostic significance of PET-CT performed after first-line therapy in patients with FL treated in the prospective Primary Rituximab and Maintenance (PRIMA) study. Results of PET-CT scans performed after induction immunochemotherapy were recorded retrospectively. Patients went on to either observation or rituximab maintenance per protocol independent of the PET-CT result. Patient characteristics and outcomes were then evaluated. Of 122 PET-CT scansperformed at the end of the induction immunochemotherapy, 32 (26%) were reported as positive by the local investigator.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FD - Onkologie a hematologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2011
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Clinical Oncology
ISSN
0732-183X
e-ISSN
—
Svazek periodika
29
Číslo periodika v rámci svazku
23
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
7
Strana od-do
3194-3200
Kód UT WoS článku
000293628400021
EID výsledku v databázi Scopus
—